Document is current
Any future updates will be listed below
-
Authors
González-Conde, Miriam
Yáñez, Celso
Abuín, Carmen
Keup, Corinna
Lago-Lestón, Ramón
Aybar, Maribel
Pedrouzo, Lucía
Palacios, Patricia
Curiel, Teresa
Cueva, Juan
Rodríguez, Carmela
Carmona, Marta
Cortegoso, Alexandra
García-Caballero, Tomás
Muinelo-Romay, Laura
Kasimir-Bauer, Sabine
López-López, Rafael
Costa, Clotilde https://orcid.org/0000-0001-7327-2259
-
Funding
Funding for this research was provided by:
Axencia Galega de Innovación (IN853B 2018/03)
Instituto de Salud Carlos III (PI18/00183, FI19/00140)
Fundación Científica Asociación Española Contra el Cáncer (INVES211437COST)
- License Information
-
More Information
Article History
Received: 24 October 2024
Accepted: 8 March 2025
First Online: 4 April 2025
Declarations
:
: All procedures followed the Helsinki Declaration guidelines and were approved by two separate ethics committees (the Ethics Committee of Galicia under approval reference number 2015/772 and the Ethics Commission of the University Duisburg-Essen under approval reference number 12-5265-BO). All patients provided written informed consent.
: Not applicable. No individual person’s data were included.
: Rafael López (R.L.). reports grants and personal fees from Roche, Merck, AstraZeneca, Bayer, Pharmamar, and Leo and personal fees and nonfinancial support from Bristol-Myers Squibb and Novartis, outside of the submitted work. S.K.-B. is a consultant for QIAGEN. C.K. received support for travel expenses from QIAGEN and was involved in the conduction of two independent research Grants sponsored by Pfizer Pharma GmbH. The other authors declare no conflicts of interest.
